Quick Takeaways
- Leviticus Partners LP filed SCHEDULE 13G/A for HARVARD BIOSCIENCE INC Common Stock (HBIO).
- Disclosed ownership: 8.6%.
- Date of event: 01 Apr 2025.
Leviticus Partners LP - 01 Apr 2025 SCHEDULE 13G/A Report for HARVARD BIOSCIENCE INC Common Stock (HBIO)
- Filing Manager
- Leviticus Partners LP
- Reporting Manager
- Leviticus Partners LP
- Security
- HARVARD BIOSCIENCE INC Common Stock
- Symbol
- HBIO
- Shares outstanding
- 43,841,302 shares
- Disclosed Ownership
- 3,770,352 shares
- Ownership
- 8.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Apr 2025, 09:49:39 UTC
- Date of event
- 01 Apr 2025
- Previous filing
- 17 Mar 2025
- Next filing
- 14 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Leviticus Partners LP disclosed 8.6% ownership in HARVARD BIOSCIENCE INC Common Stock (HBIO) on 01 Apr 2025."
What Changed
- Previous schedule filing date: 17 Mar 2025.
- Current filing was accepted on 08 Apr 2025, 09:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Leviticus Partners LP | 8.6% | 3,770,352 | 3,646,036 | 0 | Adam M Hutt | Managing Member | |
| AMH Equity LLC | 8.6% | 3,770,352 | 124,316 | 0 | Adam M Hutt | Managing Member |